Novel PEGylated basal insulin LY2605541 has a preferential hepatic effect on glucose metabolism (Q42031194)

From Wikidata
Jump to navigation Jump to search
scientific article published on 2 October 2013
edit
Language Label Description Also known as
English
Novel PEGylated basal insulin LY2605541 has a preferential hepatic effect on glucose metabolism
scientific article published on 2 October 2013

    Statements

    Novel PEGylated basal insulin LY2605541 has a preferential hepatic effect on glucose metabolism (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit